GMP-compliant in-house logistics: Requirements for internal transport processes

Digital in-house logistics creates traceable and GMP-compliant internal transport processes between laboratory, quality assurance, and production. (Copyright: COSYS)

In pharmaceutical companies, GMP requirements are often related to production, documentation, and quality assurance. At the same time, internal transportation processes are increasingly coming into focus. This is because samples, raw materials, release documents, consumables, laboratory equipment, reference samples, packaging materials, or IT equipment change locations multiple times within a site each day.

Risks arise precisely at these transition points. Materials are stored temporarily, handovers are not documented, or transports occur outside defined processes. In GMP-regulated environments, this can cause not only delays but also additional documentation and testing efforts.

Internal logistics is therefore increasingly developing into a quality-relevant process.

What GMP requires of internal transport processes

GMP does not mean that every internal movement must be fully automated. What matters is that processes are traceable, controlled, and reproducible. For internal transports, this primarily means transparency throughout the entire process.

Responsible personnel must be able to trace when materials were received, who conducted the transport, whether handovers took place, and whether defined process steps were followed. Internal transports are particularly critical between:

– Goods receipt and quality control
– Laboratory and production
– Release and storage areas
– Documentation and archiving processes

Once information is managed outside of the actual material flow, media breaks and additional risks occur.

Where traditional in-house logistics reach their limits

Many internal transport processes are organized historically. Transport orders are sent via email, materials are announced by phone, or deliveries are organized through collection rounds. Employees document handovers retrospectively or search for information across multiple systems.

Especially in larger pharmaceutical companies with several buildings or laboratory areas, this significantly prolongs internal throughput times. Typical consequences include delayed approvals, search efforts, missing status information, and additional effort during audits or internal quality checks. Additionally, valuable resources are tied up, often due to a lack of transparency.

How digital in-house logistics supports GMP processes

With COSYS in-house logistics software, internal transports are digitally recorded and continuously documented right from receipt. Shipments, materials, or operational supplies are captured via smartphone or MDE device and directly assigned to the target area. Each movement automatically generates status information and timestamps. This creates a complete shipment history within the site.

For pharmaceutical companies, this means: fewer media breaks, better traceability, and a much easier preparation for internal audits. The ability to consolidate different types of transports within one platform is particularly relevant – for example, sample logistics, document transports, material supply, or asset tracking. Dashboards and evaluations additionally provide transparency regarding throughput times, transport volume, and bottlenecks.

Smart lockers create secure and documented handovers

Another bottleneck often occurs during the final handover. Materials or documents are waiting for personal delivery or are moved multiple times. This prolongs internal routes and makes documentation more complex. COSYS smart lockers provide a controlled handover point here.

After storage, the recipient is automatically informed and retrieves the shipment via QR code, PIN, or employee ID card. Every storage and retrieval remains documented. This results in fewer interruptions in laboratory and production workflows and simultaneously increases transparency of internal material movements.

GMP-compliant processes often start between two doors

Many optimization potentials in pharmaceutical companies do not lie in additional facilities or more personnel but in clearly defined internal workflows. Digital in-house logistics and smart lockers lay the foundation for organizing internal transports in a traceable, efficient, and audit-proof manner.